NASAL DECONGESTANT PE
- Product NDC
- 73581-204
- 11-digit product format
- 735810204
- Labeler code
- 73581
- Product ID
- 73581-204_0e13a1f1-87bb-b26e-e063-6294a90a87f8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- PHENYLPHRINE HCL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- YYBA CORP
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-08-03
- Substance
- PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 25 mg/1
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NASAL DECONGESTANT PE
- Brand name suffix
- 10mg
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PHENYLEPHRINE HYDROCHLORIDE | 25 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 04JA59TNSJ |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 73581-204-02 | NASAL DECONGESTANT PE10mg | 200 in 1 BOTTLE | TABLET | 200 | | 6 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 73581-204 | NASAL DECONGESTANT PE 10MG (PHENYLPHRINE HCL) TABLET [YYBA CORP] | 6 | Current NDC, Legacy NDC, 1 package rows | 20240104_05824fc4-ef3f-4ebb-b601-252f76ad60ef.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 73581-204-02 | 73581020402 | 200 TABLET in 1 BOTTLE (73581-204-02) | 200 tablet | 2021-08-03 | 0000-00-00 | No | No | Current |